Intermountain Health has developed a electronic decision support tool to help doctors provide the best care for pneumonia. The purpose of this study is to enhance the existing tool (called ePneumonia (electronic Pneumonia) or ePNa) so that it can be used at other institutions, and to test deployment of the tool at another institution's hospitals.
This study as funded by the AHRQ (Agency for Healthcare Research and Quality) involves making the current ePNa system a "SMART on FHIR" compatible application that will enable the same core software and processes to work across the Cerner and Epic electronic health record platforms. The investigators will then engage with emergency department providers and patients to improve user centered design, considering clinician preferences and feedback for use as well as patient needs for information. Finally, the investigators will evaluate the feasibility and acceptability via a pilot implementation trial of the interoperable ePNa platform at two Vanderbilt affiliated hospitals.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6,917
Real-time, automated clinical decision support tool for pneumonia (called "ePNa")
14-day hospital-free days
14-day hospital-free days (a metric which captures outpatient disposition from the emergency department, secondary hospital admission, and length of stay)
Time frame: 14 days after initial presentation to the emergency department
30-day all-cause mortality
Time frame: At 30 days after initial ED presentation
ED length of stay (hours)
Time frame: At ED discharge
ICU length of stay (days)
Time frame: At ICU discharge
Number of patients admitted to floor who are subsequently transferred to ICU within 72 hours
Time frame: At 72 hours after inpatient admission
Time from ED presentation to first antibiotic dose (minutes)
Time frame: At time of first antibiotic dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.